Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Plasma Mir-183-5P in Colorectal Cancer Patients As Potential Predictive Lymph Node Metastasis Marker Publisher Pubmed



Sanjabi F1, 2, 5 ; Nekouian R2, 5 ; Fattahi A3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran
  3. 3. Center for Research and Training in Skin Disease and Leprosy, Iran University of Medical Sciences, Tehran, Iran
  4. 4. University of Medical Sciences, Tehran, Iran
  5. 5. Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran

Source: Journal of Cancer Research and Therapeutics Published:2022


Abstract

Background: Lymph node metastasis (LNM) is a point that often, treatment is not effective in colorectal cancer (CRC). Clinical and pathologic markers of prognosis help clinicians in selecting patients for adjuvant therapy after surgical resection in CRC. MiR-183-5p has been demonstrated to play as an oncogene in CRC, although its biological role still remains unclear. The aim of this study was to evaluate the expression of miR-183-5p in CRC and its potential relevance to clinicopathological characteristics as a prognostic biomarker. Materials and Methods: In this case-control study, 33 CRC plasma samples at stage I-II-III, as well as plasma samples from 13 healthy controls, were collected. The relative expression levels of miR-183-5p in cancer and the normal samples were measured by quantitative real-Time PCR. We analyzed their correlation with clinicopathological parameters and prognostic value. Results: Our results indicated that miR-183-5p was significantly overexpressed in CRC samples compared to healthy controls (P < 0.001) from a cutoff value of 3.9 with a sensitivity of 89% and a specificity of 91% and an AUC value of 0.74. Further analysis showed that a high plasma expression level of miR-183-5p was significantly associated with LNM and higher tumor/node/metastases stage (III) (P-value < 0.001). Conclusion: In conclusion, the overexpression of miR-183-5p is highly related to advanced clinical stage, LNM and poor prognosis of CRC, indicating that miR-183-5p may serve as a predictive biomarker for the prognosis or the aggressiveness of CRC. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.
Other Related Docs
12. Microrna Let-7 and Viral Infections: Focus on Mechanisms of Action, Cellular and Molecular Biology Letters (2022)
13. Altered Mir-223 Expression in Sputum for Diagnosis of Non-Small Cell Lung Cancer, Avicenna Journal of Medical Biotechnology (2017)
16. Upregulated Mir-410 Is Linked to Poor Prognosis in Colorectal Cancer, British Journal of Biomedical Science (2020)
17. Reproducible and Reliable Real-Time Pcr Assay to Measure Mature Form of Mir-141, Applied Immunohistochemistry and Molecular Morphology (2016)
27. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
33. Microrna a New Gate in Cancer and Human Disease: A Review, Journal of Biological Sciences (2017)